Gilead Sciences

Headquarters in USA

Gilead Sciences website

🔎 Run a search for “Gilead Sciences”

Get RSS feed of these results

All stories

Story
26 June 2020

Gilead, AIDS Healthcare Foundation & access to medicines - 2011

AIDS Healthcare Foundation has recently raised concerns about the impacts of Gilead Sciences' pricing for HIV/AIDS drugs on US state drug assistance programmes for the poor:...

See full story

Article
16 June 2020
+ Português - Hide

Author: Repórter Brasil

“Remdesivir: por que o único remédio aprovado para coronavírus deve chegar com preço exorbitante ao Brasil. Acusada de abuso de monopólio e violação da lei de patentes, a farmacêutica norte-americana Gilead planeja lucrar “por vários anos” com o...

Read more

Company non-response
13 April 2020

Gilead Sciences did not respond

Gilead Sciences did not respond to a call from Public Citizen to "commit... to license the right and needed know-how to manufacture remdesivir to all qualified producers, in exchange for a modest royalty."

Read more

Story
27 March 2020

USA: Gilead Sciences granted status to exclusively profit off of potential COVID-19 treatment; company requests govt. rescind designation after public outcry

On 23 March 2020, the US Food and Drug Administration granted Gilead Sciences “orphan” drug status for its antiviral drug, remdesivir, which is being tested as a potential treatment for COVID-19. This status would allow the pharmaceutical company to...

See full story

Article
11 November 2019
+ Português - Hide

Author: Diego Junqueira, Repórter Brasil (Brazil)

“Por que o Brasil paga até R$ 1.400 por remédio que custa R$ 34”, 08 de novembro de 2019...

Read more

Article
30 September 2019

Equileap publishes 2019 ranking of companies on gender equality in the workplace

Author: Equileap

Equileap researched 3,519 companies in 23 developed economies, representing 98 million employees, and ranked them based on 19 gender equality criteria... There has been an increase in the average score of the 100 best performing companies over the past...

Read more

Article
20 August 2019
+ Português - Hide

Author: Diego Junqueira, Repórter Brasil (Brazil)

“Investigação sobre setor farmacêutico revela rombo de R$ 170 mi, e pacientes com câncer ficam sem tratamento”, 15 de agosto de 2019...

Read more

Article
15 April 2019
+ Português - Hide

Author: Christopher Rowland, The Washington Post (USA)/Grupo de Trabalho Sobre Propriedade Intelectual (Brazil)

“Contribuinte paga pesquisas e farmacêuticas lucram com patentes concedidas pelo governo”, 1º de abril de 2019...

Read more

Story
25 September 2018
+ Português - Hide

Felizmente liminar foi concedida pela justiça federal que determinou a anulação do ato administrativo do Instituto Nacional da Propriedade Industrial (INPI) que concedia a patente do fármaco antiviral sofosbuvir em favor das empresas Gilead Pharmasset...

See full story

Story
25 April 2018

USA: Corporations increasingly vocal on social issues but still mostly lobbying for lower taxes - Oxfam America report

See full story